Table 3.
Pre-seasonal omalizumab is more effective than traditional pharmacotherapy.
Pre-seasonal omalizumab | Traditional pharmacotherapy | P-value | |
---|---|---|---|
Baseline CSMS | 4.00[2.83,4.96] | 2.88[2.25,4.25] | 0.000 |
CSMS after treatment | 0.67[0.00,1.83] | 1.42[0.71,2.29] | 0.017 |
CSMS improvement1 | 2.75 ± 1.42 | 1.22 ± 0.99 | 0.000 |
1CSMS improvement: CSMS after treatment – baseline CSMS.